Dec 21, 2018 by Motley Fool StaffWhat’s Driving China’s Biotech Revolution?China’s State Drug Administration changed its regulatory process.
Dec 21, 2018 by Motley Fool StaffWhy Are Skechers Shares Getting Stepped On?Listener Matt wants the Fools' views on this footwear stock.
Dec 21, 2018 by Motley Fool StaffHow Will Europe's Woes Impact U.S. Apparel Sellers?Many have looked across the Atlantic in search of sales growth.
Dec 21, 2018 by Motley Fool StaffOur Top Stock Idea in China’s Biotech RevolutionWhether you're in the U.S. or China, immuno-oncology is one of the hottest areas in biotech right now.
Dec 20, 2018 by Motley Fool StaffCan You Handle a Bumpy Ride Like Uxin?China's used-car leader sped uphill over the past two weeks. But before that, shareholders were turning green.
Dec 18, 2018 by Motley Fool StaffThe Market Cap Game Show: Episode 6And for the first time, we have a new contestant!
Dec 18, 2018 by Motley Fool StaffHow Did FedEx, UPS, and the U.S. Postal Service Handle Holiday Shipping?Demand is increasing, but the three big players are doing surprisingly well.
Dec 18, 2018 by Motley Fool StaffTake-Two’s Red Dead Redemption 2 Has Smashed RecordThe game has sold more than 17 million units since its October launch.
Dec 18, 2018 by Motley Fool StaffHow Amazon’s Alexa Stole ChristmasThe company’s Echo devices and Fire sticks were huge sellers during the Thanksgiving sales period.
Dec 18, 2018 by Motley Fool StaffAmazon's Biggest Move This Year: Taking Aim at HealthcareThe e-commerce giant is dipping its toes into the $3.3 trillion healthcare market.
Dec 18, 2018 by Motley Fool StaffNintendo Switch Has Arrived as a Major PlayerThe console has been a fast seller, and it’s a clear rival for Xbox One and PlayStation 4.
Dec 18, 2018 by Motley Fool StaffHealthcare: Deals, Deals, and More Deals in 2018Highlighting some of the most important healthcare mergers and acquisitions of this year.
Dec 18, 2018 by Motley Fool StaffIs Moderna’s Huge IPO in 2018 Worth the Hype?Here’s what you should know about the public offering of this biotech unicorn this year.
Dec 18, 2018 by Motley Fool StaffThis Could Be the Biggest Marijuana News in 2018Canada’s landmark recreational marijuana market opening overshadowed this important advance.
Dec 18, 2018 by Motley Fool StaffHere Are Biotech’s Big Pipeline Disappointments in 2018A number of companies suffered setbacks this year.
Dec 18, 2018 by Motley Fool StaffGene-Editing Stocks Took Stutter Steps Forward in 2018Top biotech stocks are making progress, but it was slow going this year.
Dec 18, 2018 by Motley Fool StaffRNAi Goes Big-Time in 2018A first-in-kind FDA approval catapulted this treatment approach into the spotlight.
Dec 18, 2018 by Motley Fool StaffImmuno-Oncology Suffered a Setback in 2018. What’s Next?Checkpoint inhibitors remain top sellers, but it wasn’t all rosy news this year.
Dec 18, 2018 by Motley Fool StaffWhat Happened With CAR-T Stocks in 2018Here’s how CAR-T therapies did in their first full year on the market.
Dec 17, 2018 by Motley Fool StaffShould the U.S. Postal Service Raise Its Rates?A task force believes package delivery should be more expensive.
